Meletios Therapeutics

About:

Meletios Therapeutics is a biotech company that develops antiviral molecules for unmet emergency medical needs.

Website: https://meletiostx.com

Twitter/X: meletios_tx

Top Investors: European Innovation Council

Description:

Meletios Therapeutics is an operator of a biotechnology company intended to fulfill the medical need for antiviral molecules against current and emerging diseases. The company offers antiviral drugs by targeting host mechanisms that are hijacked by viruses, enabling healthcare institutions to treat a range of pathologies.

Total Funding Amount:

5.2M EUR

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Lyon, Rhone-Alpes, France

Founded Date:

2020-04-01

Contact Email:

contact(AT)meletiostx.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2022-11-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai